UCB News
Most Popular UCB Story
FDA announces several approvals
It's a busy Monday morning at the FDA as the agency announced several approvals. Here's the run-down:
The FDA has approved Pfizer and UCB's Toviaz extended-release tablets for the treatment of Read more...
Latest Headlines
- October 12, 2010
- June 11, 2010
- November 17, 2009
- September 24, 2009
- August 27, 2009
- May 14, 2009
- November 3, 2008
- October 20, 2008
- July 30, 2008
- July 1, 2008
- April 24, 2008
- November 16, 2007
- January 3, 2007
- October 31, 2006
- October 25, 2006
- October 11, 2006
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
